Vilobelimab
Product Specifications
CAS Number
2250440-41-4
Target
SARS-CoV, Complement System
Related Pathways
Immunology/Inflammation, Microbiology/Virology
Purity
0.99
Bioactivity
Vilobelimab (CaCP-29) is a human-mouse chimeric IgG antibody targeting human complement component 5a, a C5a inhibitor that inhibits neutrophil activation, and can be used for the study of systemic inflammation caused by SARS-CoV-2 infection.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2068895-01 0.1 mL
APC/CY7-Linked Polyclonal Antibody to Fibroblast Growth Factor 3 (FGF3)
Sign In for Pricing
View Details 
MBS2068895-02 0.2 mL
APC/CY7-Linked Polyclonal Antibody to Fibroblast Growth Factor 3 (FGF3)
Sign In for Pricing
View Details 
MBS2068895-03 0.5 mL
APC/CY7-Linked Polyclonal Antibody to Fibroblast Growth Factor 3 (FGF3)
Sign In for Pricing
View Details MBS2068895-04 1 mL
APC/CY7-Linked Polyclonal Antibody to Fibroblast Growth Factor 3 (FGF3)
Sign In for Pricing
View Details 
MBS2068895-05 5 mL
APC/CY7-Linked Polyclonal Antibody to Fibroblast Growth Factor 3 (FGF3)
Sign In for Pricing
View Details MBS2068895-06 5x 5 mL
APC/CY7-Linked Polyclonal Antibody to Fibroblast Growth Factor 3 (FGF3)
Sign In for Pricing
View Details